Ladon Therapeutics is a clinical stage biopharmaceutical company.
Ladon discovers, develops and commercializes A3SMO® (Artificial Amino Acid-based Small Molecules) first-in-class medicines and diagnostics for autoimmune and genetic diseases with major unmet medical needs.
Ladon brings together breakthrough Artificial Amino Acid-based Small Molecule chemistry and a state-of-the-art diagnostic laboratory from gene expression profiling to in vivo disease models to characterize, test and evaluate A3SMO® drug candidates.
Company Details
- Employees
- 3
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.ladon.life
Ladon Therapeutics Questions
Ladon Therapeutics's website is http://www.ladon.life
Ladon Therapeutics's LinkedIn profile is https://www.linkedin.com/company/ladon-therapeutics
Ladon Therapeutics has
3 employees.
View email and phone details for 3
employees at Ladon Therapeutics.
Ladon Therapeutics's industry is
Biotechnology Research
Ladon Therapeutics's top competitors are
Cornerstone Pharmaceuticals,
Gan & Lee Pharmaceuticals,
Vaccinex,
Launch Therapeutics,
Zenith Therapeutics,
Serda Therapeutics,
Basecure Therapeutics Inc.,
Inventiva Pharma,
Apollomics,
Tagworks Pharmaceuticals.
Ladon Therapeutics's categories are Biotechnology Research
Ladon Therapeutics's founding year is 2019
